Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry v3.7.0 was added to the record history and the older revision v3.6.6 was removed, indicating the page has been updated to reflect a newer version of the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.6 was added to the study history, and the previous revision v3.6.5 was removed from the current history.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page update introduces Revision: v3.6.5 and removes several history-related sections from the study record view, altering how past changes and results are accessed within the history page.SummaryDifference11%

- Check81 days agoChange DetectedA new site revision entry, v3.6.4, has been added to the Study Record History, replacing the previous revision v3.6.3.SummaryDifference0.1%

- Check102 days agoChange DetectedThe record history now shows a new revision (v3.6.3) replacing the previous v3.6.2. This indicates a minor platform update rather than a content change on the page.SummaryDifference0.1%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.